Q1 2024 · 13F-HR
BOONE CAPITAL MANAGEMENT LLCholdings as filed
Filed 2024-05-15 · accession 0001214659-24-009294
$494.4M
Reported value
21
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 91529Y106 | UNM | UNUM GROUP | $55.0M | 11.1% | 1,025,027 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $47.9M | 9.69% | 131,926 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $35.2M | 7.12% | 85,716 | Common | SOLE |
| 194014502 | ENOV | ENOVIS CORPORATION | $35.1M | 7.11% | 562,739 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $29.8M | 6.03% | 697,957 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $28.4M | 5.75% | 529,825 | Common | SOLE |
| 08579W103 | BERYEUR | BERRY GLOBAL GROUP INC | $27.2M | 5.51% | 450,101 | Common | SOLE |
| 03209R103 | AMPH | AMPHASTAR PHARMACEUTICALS IN | $26.6M | 5.39% | 606,688 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $25.5M | 5.15% | 310,462 | Common | SOLE |
| 090572207 | BIO | BIO RAD LABS INC | $25.0M | 5.06% | 72,344 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $23.3M | 4.72% | 531,967 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $22.1M | 4.48% | 609,104 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $16.4M | 3.32% | 65,811 | Common | SOLE |
| 59064R109 | MLAB | MESA LABS INC | $14.6M | 2.96% | 133,394 | Common | SOLE |
| 68752M108 | OFIX | ORTHOFIX MED INC | $14.1M | 2.86% | 974,502 | Common | SOLE |
| 92556V106 | VTRS | VIATRIS INC | $13.5M | 2.74% | 1,133,591 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $12.5M | 2.54% | 291,403 | Common | SOLE |
| 421906108 | HCSG | HEALTHCARE SVCS GROUP INC | $11.6M | 2.34% | 926,455 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $11.4M | 2.30% | 451,898 | Common | SOLE |
| 70805E109 | PNTG | PENNANT GROUP INC | $11.1M | 2.24% | 564,192 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $7.8M | 1.57% | 330,151 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.